Dose-modifying factor for captopril for mitigation of radiation injury to normal lung
about
2013 Dade W. Moeller lecture: medical countermeasures against radiological terrorismPractical advice on calculating confidence intervals for radioprotection effects and reducing animal numbers in radiation countermeasure experimentsEffects of ionizing radiation on biological molecules--mechanisms of damage and emerging methods of detectionModel development and use of ACE inhibitors for preclinical mitigation of radiation-induced injury to multiple organs.Whole-thorax irradiation induces hypoxic respiratory failure, pleural effusions and cardiac remodeling.Enhanced survival from radiation pneumonitis by combined irradiation to the skinMedical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.Changes in miRNA in the lung and whole blood after whole thorax irradiation in rats.An Appreciation for the Rabbit Ladderlike Modeling of Radiation-induced Lung Injury with High-energy X-RayEnalapril mitigates focal alveolar lesions, a histological marker of late pulmonary injury by radiation to the lungRadioprotectors - the evergreen topic.A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures.Biomarkers for Radiation Pneumonitis Using Noninvasive Molecular Imaging.Combined Hydration and Antibiotics with Lisinopril to Mitigate Acute and Delayed High-dose Radiation Injuries to Multiple Organs.Association of DNA repair gene polymorphisms with the risk of radiation pneumonitis in lung cancer patients.GSTP1 Ile105Val polymorphism might be associated with the risk of radiation pneumonitis among lung cancer patients in Chinese population: A prospective study.
P2860
Q27026683-443424ED-D706-4336-AD3D-E4729553949EQ30574119-3F612B02-BB76-461A-BF2C-39B0603B7F53Q33767975-E16136DF-18CC-4615-9F05-AA18760B945FQ34667903-6A22DC17-B6A1-4387-B77A-E04BC7C1449FQ35234011-5AD16446-C989-4CC3-95E3-C63B156DA640Q35234436-FA398BBB-3E50-4427-BE57-57F85BCC75A3Q35566671-A5FB83B9-09B5-432F-AB41-932C3E73BDAEQ36311716-BB271834-F719-4891-B70C-6C713250B183Q36523196-B7E46E85-68FD-413E-80CB-822191882D37Q36969059-F426E022-48BF-4A94-8F52-55E472833C49Q38153018-B04DB2D5-0C8C-4E18-AE72-9222F78A7485Q39398444-43344A49-D81B-4FE1-9341-D8A593642C17Q41348236-39335329-891A-4412-8D0D-C341BF489111Q42703715-453A0967-65C8-4D81-BFA6-45F70590403FQ49209422-20EDF702-5463-45D6-85B1-56A46786603AQ55402966-1C228C2C-DE72-4E24-B8A6-DDB96433D01F
P2860
Dose-modifying factor for captopril for mitigation of radiation injury to normal lung
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Dose-modifying factor for captopril for mitigation of radiation injury to normal lung
@ast
Dose-modifying factor for captopril for mitigation of radiation injury to normal lung
@en
type
label
Dose-modifying factor for captopril for mitigation of radiation injury to normal lung
@ast
Dose-modifying factor for captopril for mitigation of radiation injury to normal lung
@en
prefLabel
Dose-modifying factor for captopril for mitigation of radiation injury to normal lung
@ast
Dose-modifying factor for captopril for mitigation of radiation injury to normal lung
@en
P2093
P2860
P356
P1476
Dose-modifying factor for captopril for mitigation of radiation injury to normal lung
@en
P2093
Aniko Szabo
Brian L Fish
Elizabeth R Jacobs
John E Moulder
Meetha Medhora
P2860
P304
P356
10.1093/JRR/RRS004
P577
2012-06-06T00:00:00Z